perylene has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babinčák, M; Buríková, M; Fedoročko, P; Jendželovská, Z; Jendželovský, R; Košuth, J; Majerník, M; Ševc, J; Tonelli Gombalová, Z | 1 |
| Chen, F; Dai, X; Li, Y; Ni, Y; Shao, H; Sun, Z; Xu, K; Zhang, J | 1 |
| Ali, SM; Bhuvaneswari, R; Chin, WW; Gan, YY; Lucky, SS; Olivo, M; Soo, KC | 1 |
| Dankovcík, R; Mirossay, A; Mirossay, L; Mojzis, J; Ostró, A; Sarisský, M; Stupáková, V; Urdzík, P; Varinská, L | 1 |
| de Witte, P; Lerut, E; Marysael, T; Ni, Y | 1 |
| Bhuvaneswari, R; Chee, SK; Olivo, M; Yuen, GY | 1 |
| Agostinis, P; Buytaert, E; de Witte, P; Dewaele, M; Hendrickx, N; Janssens, S; Marsboom, G; Van Boven, M; Vandenheede, JR | 1 |
| Olivo, M; Soo, KC; Yee, KK | 1 |
| Kiesslich, T; Krammer, B; Plaetzer, K | 1 |
1 review(s) available for perylene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Mitochondria; Neoplasms; Neovascularization, Pathologic; Perylene; Photochemotherapy; Radiation-Sensitizing Agents; Signal Transduction | 2006 |
8 other study(ies) available for perylene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Topics: Angiogenesis Inducing Agents; Animals; Anthracenes; Biomarkers; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Colorectal Neoplasms; Disease Models, Animal; Gene Expression; Humans; Neovascularization, Pathologic; Perylene; Phloroglucinol; Photochemotherapy; Photosensitizing Agents; Terpenes | 2019 |
Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.
Topics: Animals; Anthracenes; Autoradiography; Disease Models, Animal; Iodine Radioisotopes; Necrosis; Neoplasms; Neovascularization, Pathologic; Perylene; Rabbits; Radiopharmaceuticals; Random Allocation; Tomography, Emission-Computed, Single-Photon | 2015 |
Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.
Topics: Angiogenic Proteins; Animals; Anthracenes; Blotting, Western; Cell Line, Tumor; Endoscopy; Fluorescence; Gene Expression Profiling; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Neovascularization, Pathologic; Perylene; Photochemotherapy; Photosensitizing Agents; Polymerase Chain Reaction; Protein Array Analysis; Time Factors; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.
Topics: Anthracenes; Cell Line, Tumor; Cell Movement; DNA Fragmentation; Endothelial Cells; Gelatinases; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Perylene; Photochemotherapy; Photosensitizing Agents | 2009 |
Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors.
Topics: Animals; Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Mice; Mice, Inbred C3H; Necrosis; Neoplasms; Neovascularization, Pathologic; Organophosphorus Compounds; Perylene; Telomere-Binding Proteins; Xanthones | 2011 |
Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Blotting, Western; Cell Movement; Cetuximab; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Neovascularization, Physiologic; Perylene; Photochemotherapy; Photosensitizing Agents; Random Allocation; Signal Transduction; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2011 |
Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.
Topics: Anthracenes; Cell Line; Cell Movement; Drug Delivery Systems; Endothelial Cells; Enzyme Inhibitors; HeLa Cells; Humans; Mitogen-Activated Protein Kinase 14; Neovascularization, Pathologic; Perylene; Photochemotherapy; Photosensitizing Agents; Protein Kinase C; Signal Transduction | 2005 |
Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Celecoxib; Cyclooxygenase 2; Drug Therapy, Combination; Evans Blue; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Male; Mice; Mice, Inbred BALB C; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neovascularization, Pathologic; Perylene; Photochemotherapy; Pyrazoles; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |